Avenir Wellness Solutions, Inc.
AVRW
Other OTC0.00
USD
- -
- -
CIK
0001643301
ISIN
US23127P1049
CUSIP
23127P104
Return %
Stock
S&P500
1Y
-98.57
26.57
3Y
-99.84
76.60
5Y
-99.97
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Joel Bennett
- Full Time Employees
- 11
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 5805 Sepulveda Boulevard Sherman Oaks CA United States of America 91411
- IPO Date
- Feb 3, 2017
- CIK
- 0001643301
- Website
- avenirwellness.com
- Similar Companies
- Business
- Avenir Wellness Solutions, Inc. is a broad platform technology company specializing in the development and commercialization of science-backed nutraceutical formulations and patented topical and nutraceutical delivery systems designed to enhance efficacy and consumer wellness. The company's principal products include wellness, beauty, and pet care offerings marketed under the Seratopical, Seratopical Revolution, SeraLabs, and Nutri-Strips brand names. These products are sold through mass retailers, grocery chains, drug and convenience stores, private label arrangements, multi-level marketers, and direct-to-consumer channels including online subscriptions. Incorporated in 2014 and headquartered in Sherman Oaks, California, Avenir has a focus on proprietary delivery technologies supported by approximately 15 patents aimed at improving product absorption, safety, and consumer experience. Recent major company developments include the 2022 rebranding from CURE Pharmaceutical Holding Corp. to Avenir Wellness Solutions, reflecting a strategic shift towards expanding its wellness and beauty portfolio beyond its original pharmaceutical focus. In late 2024, Avenir resolved an $8.7 million convertible debt dispute through a global settlement with Ionic Ventures, converting significant debt into equity and obtaining more favorable financing terms, thereby strengthening its balance sheet and enabling further expansion initiatives. The company has also launched new products such as the patented DNA Complex, a deep nano-active peptide formulation for skin care, supported by strategic partnerships with high-profile endorsers like Nicole Kidman and medical professionals. Avenir continues to pursue a growth strategy that includes expanding retail distribution, increasing international presence, leveraging influencer partnerships, and broadening its product portfolio through internal innovation and acquisitions. Avenir Wellness Solutions operates primarily in the consumer staples sector, serving beauty, health, and wellness markets primarily in the United States with plans for global distribution. Its operations are conducted through its wholly owned subsidiary The Sera Labs, Inc., and it maintains a strong emphasis on intellectual property development and monetization through product sales, patent licensing, and royalty agreements. The company focuses on consumers seeking scientifically advanced wellness and beauty solutions, positioning itself at the intersection of health, technology, and lifestyle enhancement.
Avenir Wellness Solutions Announces Global Settlement with Ionic Ventures, Eliminating Convertible Debt
Avenir Wellness Solutions Reports Fourth Quarter 2023 Results
Avenir Wellness Solutions Reports Third Quarter 2023 Results
Avenir Wellness Solutions Announces Return of Stock Trading Back to OTCQB Market